Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Dare Bioscience (DARE) Profit After Tax (2016 - 2025)

Dare Bioscience (DARE) has disclosed Profit After Tax for 11 consecutive years, with -$3.6 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Profit After Tax rose 24.24% year-over-year to -$3.6 million, compared with a TTM value of -$17.5 million through Sep 2025, down 385.76%, and an annual FY2024 reading of -$4.1 million, up 86.41% over the prior year.
  • Profit After Tax was -$3.6 million for Q3 2025 at Dare Bioscience, up from -$4.0 million in the prior quarter.
  • Across five years, Profit After Tax topped out at $12.9 million in Q2 2024 and bottomed at -$15.9 million in Q4 2022.
  • Average Profit After Tax over 5 years is -$6.1 million, with a median of -$7.0 million recorded in 2022.
  • The sharpest move saw Profit After Tax crashed 2216.49% in 2023, then soared 247.34% in 2024.
  • Year by year, Profit After Tax stood at -$9.5 million in 2021, then tumbled by 67.94% to -$15.9 million in 2022, then skyrocketed by 68.29% to -$5.1 million in 2023, then fell by 9.79% to -$5.6 million in 2024, then skyrocketed by 35.84% to -$3.6 million in 2025.
  • Business Quant data shows Profit After Tax for DARE at -$3.6 million in Q3 2025, -$4.0 million in Q2 2025, and -$4.4 million in Q1 2025.